Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital

Non-medical switch from originator to biosimilar infliximab in patients with inflammatory arthritis: impact on s-infliximab and antidrug antibodies. Results from the Danish Rheumatological Biobank and the DANBIO registry

Research output: Contribution to journalConference abstract in journalResearchpeer-review

View graph of relations
Original languageEnglish
Article numberOP10
JournalScandinavian Journal of Rheumatology
Issue numberSuppl. 128
Pages (from-to)6-7
Number of pages2
Publication statusPublished - 2016

ID: 49894981